Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools
暂无分享,去创建一个
H. Schünemann | T. Eckmanns | E. Rehfuess | A. Morgan | J. Meerpohl | G. Krause | D. Matysiak-Klose | A. Takla | O. Wichmann | T. Zuiderent-Jerak | T. Harder | F. Forland | A. Jansen | R. James | H. de Carvalho Gomes | S. Ellis | Alex Sánchez-Vivar
[1] F. Forland,et al. 087 Capacities, practices and perceptions of evidence-based public health in Europe , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[2] T. Woodruff,et al. Instruments for Assessing Risk of Bias and Other Methodological Criteria of Published Animal Studies: A Systematic Review , 2013, Environmental Health Perspectives.
[3] F. Blyth,et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. , 2012, Journal of clinical epidemiology.
[4] Eva A Rehfuess,et al. Quality appraisal in systematic reviews of public health interventions: an empirical study on the impact of choice of tool on meta-analysis , 2012, Journal of Epidemiology & Community Health.
[5] H. Schünemann,et al. Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010. , 2012, Vaccine.
[6] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[7] C P Farrington,et al. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice , 2011, Epidemiology and Infection.
[8] D. Moher,et al. Development quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: pilot study of new checklists. , 2011, Journal of Clinical Epidemiology.
[9] R. Kane,et al. A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. , 2010, Journal of clinical epidemiology.
[10] Michael Kelly,et al. Evidence based public health: A review of the experience of the National Institute of Health and Clinical Excellence (NICE) of developing public health guidance in England. , 2010, Social science & medicine.
[11] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[12] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2010, Annals of Internal Medicine.
[13] D. Howells,et al. Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.
[14] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of Pharmacology and Pharmacotherapeutics.
[15] G. Guyatt,et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines , 2009, Allergy.
[16] M. Petticrew,et al. Reviewing evidence on complex social interventions: appraising implementation in systematic reviews of the health effects of organisational-level workplace interventions , 2008, Journal of Epidemiology & Community Health.
[17] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[18] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Bulletin of the World Health Organization.
[19] S. Pocock,et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.
[20] J. Higgins,et al. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. , 2007, International journal of epidemiology.
[21] David L. Sackett,et al. Evidence based medicine: What it is and what it isn't (reprinted from BMJ, vol 312, pg 71-72, 1996) , 2007 .
[22] T. Greenhalgh,et al. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources , 2005, BMJ : British Medical Journal.
[23] T. Greenhalgh,et al. Realist review - a new method of systematic review designed for complex policy interventions , 2005, Journal of health services research & policy.
[24] P. Katrak,et al. A systematic review of the content of critical appraisal tools , 2004, BMC medical research methodology.
[25] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[26] J. Bryce,et al. Evidence-based public health: moving beyond randomized trials. , 2004, American journal of public health.
[27] F. Song,et al. Evaluating non-randomised intervention studies. , 2003, Health technology assessment.
[28] J. Hay,et al. Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES , 2003, Journal of managed care pharmacy : JMCP.
[29] A. Murray,et al. Developing a quality scoring system for epidemiological surveys of genetic disorders , 2002, Clinical genetics.
[30] Peter Jüni,et al. Quality of reporting of randomized trials as a measure of methodologic quality. , 2002, JAMA.
[31] T. Jefferson,et al. Quality of systematic reviews of economic evaluations in health care. , 2002, JAMA.
[32] Timothy C Carey,et al. Systems to rate the strength of scientific evidence. , 2002, Evidence report/technology assessment.
[33] M. Egger,et al. The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.
[34] N. Black,et al. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.
[35] Andy Stergachis,et al. The Role of Cost—Consequence Analysis in Healthcare Decision—Making , 1998, PharmacoEconomics.
[36] N. Black. CONSORT , 1996, The Lancet.
[37] D. Sackett,et al. Evidence based medicine: what it is and what it isn't , 1996, BMJ.
[38] M. Cho,et al. Instruments for assessing the quality of drug studies published in the medical literature. , 1994, JAMA.
[39] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[40] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[41] 40026386 Return Undeliverable,et al. Canadian Agency for Drugs and Technologies in Health , 2009 .
[42] QUALITY ASSESSMENT TOOL FOR QUANTITATIVE STUDIES , 2008 .
[43] P. Prorok,et al. Bmc Medical Research Methodology Open Access Comparing Breast Cancer Mortality Rates Before-and-after a Change in Availability of Screening in Different Regions: Extension of the Paired Availability Design , 2022 .
[44] L W Chambers,et al. Critical appraisal of the health research literature: prevalence or incidence of a health problem. , 1998, Chronic diseases in Canada.
[45] Klaus Krippendorff,et al. Content Analysis: An Introduction to Its Methodology , 1980 .